• TFEB Drives PD-L1–Mediated Resistance to mTOR Inhibition in

  2026-05-14

  This study reveals that transcription factor EB (TFEB) directly induces PD-L1 expression in renal cell carcinoma (RCC), promoting immune evasion and resistance to mTOR inhibition. These findings highlight a mechanistic basis for combining mTOR and PD-L1 blockade to enhance therapeutic outcomes in RCC.

• Tofacitinib Citrate (CP-690550): Applied JAK3 Inhibition in

  2026-05-14

  Tofacitinib citrate (CP-690550 citrate) empowers immune regulation and inflammatory disorder research with nanomolar JAK3 selectivity. This article translates recent vascular study insights into actionable protocols, troubleshooting, and comparative workflow strategies for the modern bench scientist.

• CCK-8s Enhances ANP Secretion via NOX4–PGC-1α–PPAR Signaling

  2026-05-13

  This study demonstrates that sulfated cholecystokinin octapeptide (CCK-8s) directly promotes atrial natriuretic peptide (ANP) secretion in isolated beating rat atria through a defined NOX4–PGC-1α–PPARα/PPARγ signaling cascade. These findings clarify the molecular mechanisms linking CCK signaling, redox modulation, and cardiac peptide hormone regulation, providing a platform for future research in cardiovascular and inflammatory contexts.

• Oleanolic Acid: iNOS Induction in Dual-Loaded Liposome Resea

  2026-05-13

  Oleanolic acid’s potent iNOS induction unlocks advanced antiviral and immune pathway research when leveraged in dual-loaded liposome assays. This guide translates the latest nanoparticle exclusion HPLC breakthrough into practical, reproducible workflows—maximizing data reliability and troubleshooting efficiency for biomedical innovators.

• 4-Hydroxytamoxifen: Technical Protocols for Cancer Research

  2026-05-12

  4-Hydroxytamoxifen (SKU B6167) provides researchers with a high-purity, DMSO-soluble estrogen receptor modulator for protocols in breast cancer research, prostate cancer models, and cardiac myocyte calcium handling studies. It should not be used in workflows requiring aqueous or ethanol solubility and demands careful storage and preparation to maintain compound integrity.

• Hydrocortisone for Advanced Inflammation and Neuroprotection

  2026-05-12

  Explore hydrocortisone as a glucocorticoid hormone in cutting-edge inflammation model research and neurodegeneration assays. This article uniquely examines mechanistic depth, practical assay parameters, and insights from recent translational studies to guide experimental design.

• CFDA SE Cell Tracer Kit: Practical Guide for Cell Tracing Wo

  2026-05-11

  The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit addresses the need for durable, stable fluorescent cell labeling in cell proliferation and lineage tracing studies. It is not suitable for workflows requiring reversible or short-term cell labeling.

• Multiomics Analysis of Bifendate Mechanisms in Acute Liver I

  2026-05-11

  This study leverages multiomics approaches to elucidate how bifendate (DDB) and muaddil sapra modulate gene and protein networks in acute liver injury. The work highlights bifendate’s regulation of ncRNAs and key immune/inflammation proteins, establishing new mechanistic insights for targeted hepatoprotection.

• Optimizing Cell Assays with HRP Goat Anti-Mouse IgG (H+L) An

  2026-05-10

  This article addresses persistent challenges in cell viability and immunodetection workflows, focusing on the validated use of HRP Goat Anti-Mouse IgG (H+L) Antibody (SKU K1221). Scenario-driven Q&A blocks provide actionable, evidence-based guidance for assay optimization, reproducibility, and vendor selection, supporting biomedical researchers with literature-backed best practices.

• Methylprednisolone Sodium Succinate: Advanced Bench Applicat

  2026-05-09

  Methylprednisolone Sodium Succinate empowers reproducible anti-inflammatory and immunomodulatory research, enabling precise apoptosis induction and cytokine modulation across in vitro and in vivo models. Learn advanced workflows, quantifiable protocol enhancements, and troubleshooting tips that set APExBIO’s formulation apart for inflammation and acute injury research.

• BIIE 0246: Reliable NPY Y2 Receptor Antagonism for Lab Succe

  2026-05-08

  This article presents evidence-based strategies for employing BIIE 0246 (SKU B6836) in neuropeptide Y Y2 receptor antagonist research. Drawing on validated laboratory scenarios, it demonstrates how APExBIO’s BIIE 0246 offers reproducible results, robust protocol compatibility, and superior data confidence for cell viability, proliferation, and neurocardiac studies.

• Cl-Amidine trifluoroacetate salt: Optimizing PAD4 Assays in

  2026-05-08

  Cl-Amidine (trifluoroacetate salt) empowers researchers to dissect PAD4-driven epigenetic and inflammatory mechanisms with unmatched selectivity. This guide details actionable workflows, troubleshooting strategies, and the translational leap enabled by APExBIO’s trusted reagent in cancer, autoimmunity, and septic shock models.

• PPT (Propyl Pyrazole Triol) in ERα Research: Bench to Biomar

  2026-05-07

  PPT (Propyl Pyrazole Triol) enables precision dissection of estrogen receptor alpha (ERα) signaling in both cancer biology and gene expression workflows. This article translates the latest biomarker-driven insights and troubleshooting tactics into actionable, stepwise protocols—empowering researchers to unravel ERα-mediated pathways with robust reproducibility.

• MCC950 Sodium: Precision NLRP3 Inhibition in Inflammatory Mo

  2026-05-07

  MCC950 sodium (CRID3 sodium salt) enables highly selective, nanomolar-potency inhibition of the NLRP3 inflammasome, streamlining workflows in both macrophage and endothelial experimental systems. With robust solubility, proven pathway specificity, and workflow flexibility, it empowers researchers to dissect inflammatory and autoimmune disease mechanisms with confidence.

• Radioiodinated Balsalazide: A Selective Tracer for Colitis I

  2026-05-06

  This study presents the synthesis and evaluation of radioiodinated balsalazide as a highly selective radiotracer for imaging ulcerative colitis in mice. The protocol achieves high labeling efficiency, radiochemical purity, and demonstrates strong colonic uptake in disease models, supporting advanced inflammation research workflows.

16040 records 1/1070 page Next 12345 下5页 Last page